Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP

  • Peter J. Little
  • , Katherine D. Drennon
  • , Lisa R. Tannock

Producción científica: Articlerevisión exhaustiva

14 Citas (Scopus)

Resumen

Glucosamine via GlcNAc is a precursor for the synthesis of glycosaminoglycan (GAG) chains on proteoglycans. We previously found that proteoglycans synthesized and secreted by vascular smooth muscle cells (VSMC) in the presence of supplementary glucosamine had GAG of decreased not increased size. We investigated the possibility that the inhibition of GAG chains synthesis on proteoglycans might be related to cellular ATP depletion. Confluent primate VSMCs were exposed to glucosamine, azide, or 2-deoxyglucose (2-DG). Each of these agents depleted cell ATP content by 25-30%. All agents decreased 35S-SO4 incorporation and reduced the size of the proteoglycans, decorin and biglycan as assessed by SDS-PAGE. On withdrawal of the glucosamine, azide or 2-DG ATP levels and proteoglycan synthesis returned towards baseline values. Glucosamine decreased glucose uptake and consumption suggesting that ATP depletion was due preferential phosphorylation of glucosamine over glucose. Thus, glucosamine inhibition of proteoglycan synthesis is due, at least in part, to depletion of cellular ATP content.

Idioma originalEnglish
Páginas (desde-hasta)120-126
Número de páginas7
PublicaciónArchives of Physiology and Biochemistry
Volumen114
N.º2
DOI
EstadoPublished - 2008

Nota bibliográfica

Funding Information:
This work was supported in part by grants AT00555 and DK35816 (LT) and from the National Health and Medical Research Council of Australia (268928) (PJL). We gratefully acknowledge support by the University of Kentucky Hospital under the Physician Scientist Program.

Financiación

This work was supported in part by grants AT00555 and DK35816 (LT) and from the National Health and Medical Research Council of Australia (268928) (PJL). We gratefully acknowledge support by the University of Kentucky Hospital under the Physician Scientist Program.

FinanciadoresNúmero del financiador
National Health and Medical Research Council, Australia268928
University of Kentucky Children's Hospital
National Institute of Diabetes and Digestive and Kidney DiseasesP30DK035816
National Institute of Diabetes and Digestive and Kidney Diseases

    ASJC Scopus subject areas

    • Physiology
    • Physiology (medical)

    Huella

    Profundice en los temas de investigación de 'Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP'. En conjunto forman una huella única.

    Citar esto